These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 33371817)
1. Gossypol Reduces Metastasis and Epithelial-Mesenchymal Transition by Targeting Protease in Human Cervical Cancer. Hsieh YS; Chu SC; Huang SC; Kao SH; Lin MS; Chen PN Am J Chin Med; 2021; 49(1):181-198. PubMed ID: 33371817 [TBL] [Abstract][Full Text] [Related]
2. Berberine reverses epithelial-to-mesenchymal transition and inhibits metastasis and tumor-induced angiogenesis in human cervical cancer cells. Chu SC; Yu CC; Hsu LS; Chen KS; Su MY; Chen PN Mol Pharmacol; 2014 Dec; 86(6):609-23. PubMed ID: 25217495 [TBL] [Abstract][Full Text] [Related]
3. Antimetastatic effects of gossypol on colon cancer cells by targeting the u-PA and FAK pathways. Huang SF; Chu SC; Hsu LS; Tu YC; Chen PN; Hsieh YS Food Funct; 2019 Dec; 10(12):8172-8181. PubMed ID: 31730141 [TBL] [Abstract][Full Text] [Related]
4. Gossypol Inhibits Metastasis of Lung Cell Carcinoma by Reversing Epithelial to Mesenchymal Transition and Suppressing Proteases Activity. Hsieh YS; Yu CH; Chu SC; Lin CY; Chen PN Environ Toxicol; 2024 Nov; 39(11):5209-5221. PubMed ID: 39263880 [TBL] [Abstract][Full Text] [Related]
5. Phloretin suppresses metastasis by targeting protease and inhibits cancer stemness and angiogenesis in human cervical cancer cells. Hsiao YH; Hsieh MJ; Yang SF; Chen SP; Tsai WC; Chen PN Phytomedicine; 2019 Sep; 62():152964. PubMed ID: 31153059 [TBL] [Abstract][Full Text] [Related]
6. Rubus idaeus L. reverses epithelial-to-mesenchymal transition and suppresses cell invasion and protease activities by targeting ERK1/2 and FAK pathways in human lung cancer cells. Hsieh YS; Chu SC; Hsu LS; Chen KS; Lai MT; Yeh CH; Chen PN Food Chem Toxicol; 2013 Dec; 62():908-18. PubMed ID: 24161487 [TBL] [Abstract][Full Text] [Related]
7. CD36 promotes the epithelial-mesenchymal transition and metastasis in cervical cancer by interacting with TGF-β. Deng M; Cai X; Long L; Xie L; Ma H; Zhou Y; Liu S; Zeng C J Transl Med; 2019 Oct; 17(1):352. PubMed ID: 31655604 [TBL] [Abstract][Full Text] [Related]
8. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
9. Sildenafil Inhibits the Growth and Epithelial-to-mesenchymal Transition of Cervical Cancer via the TGF-β1/Smad2/3 Pathway. Liu P; Pei JJ; Li L; Li JW; Ke XP Curr Cancer Drug Targets; 2023; 23(2):145-158. PubMed ID: 35975844 [TBL] [Abstract][Full Text] [Related]
10. Cinnamomum cassia extracts reverses TGF-β1-induced epithelial-mesenchymal transition in human lung adenocarcinoma cells and suppresses tumor growth in vivo. Lin CY; Hsieh YH; Yang SF; Chu SC; Chen PN; Hsieh YS Environ Toxicol; 2017 Jul; 32(7):1878-1887. PubMed ID: 28258635 [TBL] [Abstract][Full Text] [Related]
11. Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets. Tyszka-Czochara M; Lasota M; Majka M Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337896 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of SEMA4C Inhibit Epithelial-Mesenchymal Transition (EMT) and the Invasion and Metastasis of Cervical Cancer Cells via Inhibiting Transforming Growth Factor-beta 1 (TGF-β1)-Induced Hela cells p38 Mitogen-Activated Protein Kinase (MAPK) Activation. Yang L; Yu Y; Xiong Z; Chen H; Tan B; Hu H Med Sci Monit; 2020 Jan; 26():e918123. PubMed ID: 31951596 [TBL] [Abstract][Full Text] [Related]
13. Duchesnea indica extract suppresses the migration of human lung adenocarcinoma cells by inhibiting epithelial-mesenchymal transition. Chen PN; Yang SF; Yu CC; Lin CY; Huang SH; Chu SC; Hsieh YS Environ Toxicol; 2017 Aug; 32(8):2053-2063. PubMed ID: 28371048 [TBL] [Abstract][Full Text] [Related]
14. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells. Cheng KY; Hao M Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743 [TBL] [Abstract][Full Text] [Related]
15. Rubus idaeus L Inhibits Invasion Potential of Human A549 Lung Cancer Cells by Suppression Epithelial-to-Mesenchymal Transition and Akt Pathway In Vitro and Reduces Tumor Growth In Vivo. Chu SC; Hsieh YS; Hsu LS; Chen KS; Chiang CC; Chen PN Integr Cancer Ther; 2014 May; 13(3):259-73. PubMed ID: 24335666 [TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV inhibits the invasion and metastasis of SiHa cervical cancer cells via the TGF‑β1‑mediated PI3K and MAPK pathways. Zhang L; Zhou J; Qin X; Huang H; Nie C Oncol Rep; 2019 May; 41(5):2975-2986. PubMed ID: 30896841 [TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760 [TBL] [Abstract][Full Text] [Related]
18. Epicatechin-3-gallate reverses TGF-β1-induced epithelial-to-mesenchymal transition and inhibits cell invasion and protease activities in human lung cancer cells. Huang SF; Horng CT; Hsieh YS; Hsieh YH; Chu SC; Chen PN Food Chem Toxicol; 2016 Aug; 94():1-10. PubMed ID: 27224248 [TBL] [Abstract][Full Text] [Related]
19. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo. Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294 [TBL] [Abstract][Full Text] [Related]
20. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states. Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]